Dr. MD Shahjalal | cancer epidemiology | Young Researcher Award

Dr. MD. Shahjalal | cancer epidemiology |Young Researcher Award

Dr. MD Shahjalal, North South University , Bangladesh

Md. Shahjalal is an accomplished public health researcher from Bangladesh 🇧🇩 with a strong academic and research background in cancer epidemiology 🎗️ and global health 🌍. He holds an MPH in Epidemiology from North South University 🎓 and a BUMS from the University of Dhaka 🏥. Currently serving as Research Coordinator at Research Rats, he has contributed to numerous international publications 📚, focusing on healthcare economics and cancer care. He is also an academic editor for PLoS ONE 🖋️ and recipient of national health research grants 🏅. His work aims to reduce disparities in cancer outcomes and improve population health 💡.

Professional Profile

ORCID

Education & Experience 

Md. Shahjalal earned his Master of Public Health (MPH) in Epidemiology 🧠 from North South University (2018–2019) and Bachelor of Unani Medicine & Surgery (BUMS) 🩺 from the University of Dhaka (2012–2017). His research journey includes roles as Research Assistant (2019–2020), Research Associate (2021–2022), and currently as Research Coordinator at Research Rats Bangladesh (2023–Present) 🔬. He also worked as a Teaching Assistant in Biostatistics at NSU 📊. Through these roles, he has developed expertise in grant writing, data analysis, and multi-disciplinary research coordination 🤝, contributing to impactful studies in cancer and public health.

Professional Development 

Shahjalal’s professional growth is rooted in continuous learning and hands-on research 📈. From coordinating multi-site cancer studies to assisting in international grant applications 💼, he has gained advanced skills in public health research, data modeling, and scientific writing 📄. His expertise spans SPSS, STATA, and EXCEL for complex analyses 📊. As an academic editor for PLoS ONE 🧑‍⚖️, he stays engaged with global research trends. His participation in peer-reviewed publications and collaborative projects reflects his commitment to evidence-based solutions in healthcare. With strong communication and leadership skills 💬, he thrives in multidisciplinary teams and policy-relevant research environments 🌐.

Research Focus 

Md. Shahjalal’s research primarily targets cancer epidemiology 🎗️, health-related quality of life, and health economics 💰. His work evaluates systemic and radiation therapy outcomes, mental health disparities 🧠, and economic burdens faced by cancer survivors in Bangladesh. He also explores nutritional issues among vulnerable populations 🥣 and investigates access disparities in cardio-oncology care ❤️. Utilizing statistical modeling and health metrics like EQ-5D-5L, he aims to inform policies for equitable healthcare access 🏥. His contributions support both national and international cancer care reforms 🌍, ensuring that scientific insights lead to real-world impact for underserved communities 📢.

Awards & Honors 

Md. Shahjalal has been recognized for his impactful research through competitive grants and editorial roles 🏆. He received the Bangladesh Health Research Grant (2024) as Principal Investigator for a TB-related nutrition project 🧪 and the General Pharmaceutical Health Research Grant (2023) as Co-Investigator on cardio-oncology care disparities ❤️. With an H-index of 8 on Scopus 📈, his scholarly influence is growing steadily. He serves as an Academic Editor for PLoS ONE 🖋️, a Scopus Q1 journal, reflecting peer recognition of his academic contributions. These honors mark him as a rising leader in public health and medical research 🌟.

Publication Top Notes

1.🎯 Radioimmunotherapy in Cancer Treatment

Title: Assessing the Clinical Effectiveness of Radioimmunotherapy with Combined Radionuclide/Monoclonal Antibody Conjugates in Cancer Treatment: Insights from Randomised Clinical Trials
Journal: Cancers (2025-04-23)
DOI: 10.3390/cancers17091413
➤ Examines advanced radioimmunotherapy effectiveness using combined agents in cancer trials.

2.💰 Cancer Treatment Costs in Bangladesh

Title: Cancer Driven Direct Medical Costs in Bangladesh: Evidence from Patient Perspective
Journal: Journal of Cancer Policy (2025-03)
DOI: 10.1016/j.jcpo.2025.100565
➤ Highlights patient-incurred medical costs and economic stress related to cancer care.

3.🏥 Unplanned Hospitalisation After Cancer Therapy

Title: Emerging Burden of Post-Cancer Therapy Complications on Unplanned Hospitalisation and Costs Among Australian Cancer Patients: A Retrospective Cohort Study Over 14 Years
Journal: Scientific Reports (2025-02-08)
DOI: 10.1038/s41598-025-89247-y
➤ Evaluates long-term health complications and hospital costs post cancer therapy in Australia.

4.🥗 Diet and Dyslipidemia in Type 2 Diabetes

Title: Association between Mediterranean Diet Adherence and Dyslipidemia Among Type-2 Diabetes Mellitus Patients in Dhaka, Bangladesh
Journal: Discover Public Health (2024-10-22)
DOI: 10.1186/s12982-024-00267-x
➤ Investigates the dietary impact on lipid profiles in diabetic patients.5.

5.💸 Economic Burden on Cancer Survivors

Title: Economic Burden of Healthcare Services on Cancer Survivors in Bangladesh
Journal: Cancer Reports (2024-08)
DOI: 10.1002/cnr2.2144
➤ Quantifies healthcare costs and financial strain on cancer survivors.

Conclusion

Md. Shahjalal demonstrates exceptional research potential and output in the interdisciplinary field of cancer epidemiology, public health, and health economics. His impactful publications, leadership in funded research, and commitment to health equity mark him as a leading candidate for the Best Researcher Award. His work not only contributes academically but also has tangible implications for national and global health policy.

 

 

 

 

Ms Raya Yashooa | Molecular biology, Genetics, Neuroscience, Cancer Research | Best Researcher Award

Ms Raya Yashooa | Molecular biology, Genetics, Neuroscience, Cancer Research | Best Researcher Award

Lecture Department of Biology, College of Education for Pure Science, at University of Al-Hamdaniya ,Iraq

Raya Khalid Yousif is an Iraqi molecular biologist with extensive expertise in microbiology, genetics, and laboratory research. With over a decade of experience in medical laboratory sciences, she is a lecturer, researcher, and skilled laboratory specialist. She has contributed significantly to Alzheimer’s disease research, infectious disease studies, and microbiological diagnostics.

Profile

orcid

scopus

Early Academic Pursuits 📚

Born on December 22, 1991, in Erbil, Iraq, Raya Khalid Yousif embarked on an academic journey driven by curiosity and dedication to the biological sciences. She earned her Bachelor of Science in Biology from the University of Baghdad in 2013, securing a distinguished sixth-ranking position. Her passion for molecular biology led her to pursue a Master of Science in Molecular Biology at Salahaddin University, Erbil, which she successfully completed in 2023. Further strengthening her academic expertise, she attended a Pedagogy course at the Lebanese French University in 2023, enhancing her teaching and research methodologies.

Professional Endeavors 🔬

With over a decade of experience in molecular biology and laboratory sciences, Raya has contributed significantly to both academia and applied research. Since February 2024, she has been serving as a Lecturer in Medical Microbiology at Knowledge University on a part-time basis. Alongside her academic role, she has been a volunteer researcher at the General Directorate of Scientific Research Center, Salahaddin University-Erbil, since April 2023, demonstrating her commitment to advancing scientific knowledge.

Her expertise extends to laboratory work, having served as a Laboratory Assistant at Catholic University-Erbil (2021-2022) and working at the Ankawa Specialized Laboratory for over a decade. These experiences have honed her practical skills in molecular diagnostics, microbiology, and clinical research.

Contributions and Research Focus 🔎

Raya Khalid Yousif specializes in molecular biology techniques, including RNA/DNA extraction, primer design, Real-Time qPCR, conventional PCR, gene cloning, and ELISA-based diagnostics. Her research has covered diverse areas such as neuroscience, oncology, genetics, molecular immunology, bacteriology, and clinical hematology. Her expertise in bioinformatics tools like NCBI, Primer3 Input, and Genome Browser enables her to conduct cutting-edge genetic analysis and molecular diagnostics.

She has played a pivotal role in multiple research projects, working extensively with histopathology, bacterial culture analysis (VITEK), and immunoassay techniques. Her work in diagnostic microbiology has contributed to advancements in disease detection and therapeutic strategies, particularly in neurological and infectious diseases.

Accolades and Recognition 🏅

Raya’s contributions to scientific research have been widely recognized. She received a Certificate of Appreciation from the General Directorate of Scientific Research Center, Salahaddin University-Erbil, in 2024 for her valuable contributions. Additionally, she has been an active manuscript reviewer for esteemed journals such as the Journal of Applied Pharmaceutical Science and Medical Science Monitor in 2023.

Her academic excellence extends to language proficiency, having attained an IELTS score of 6.0 in 2023 and undergoing advanced English training at Salahaddin University and AmidEast. She has also attended specialized workshops on Genomics and Proteomics, Infectious Disease Surveillance, and Biomedical Research Techniques, further enriching her expertise.

Impact and Influence 🌍

As an accomplished researcher, Raya has published extensively in renowned scientific journals, making significant contributions to molecular biology, infectious diseases, and neurogenetics. Some of her notable works include:

  • “The miR-146a-5p and miR-125b-5p levels as biomarkers for early prediction of Alzheimer’s disease”
  • “Telomerase Reverse Transcriptase and Telomerase RNA Component Gene Expression as Novel Biomarkers for Alzheimer’s Disease”
  • “The Outbreak of SARS-CoV-2 Variants in Iraqi Kurdistan Region”
  • “Fungal Disease Incidence and Prevalence in Iraq – Preliminary Estimates”
  • “Human ACE and ACE2 Gene Variants and COVID-19 Disease in Iraqi Kurdistan Region” (Accepted for publication)

Her book on microRNAs and telomerase gene expression in Alzheimer’s Disease serves as a valuable resource for researchers exploring neurodegenerative disorders.

Legacy and Future Contributions 🚀

Raya Khalid Yousif’s dedication to research and education positions her as a leading figure in molecular biology and biomedical sciences. With a strong foundation in academia and practical laboratory expertise, she aspires to train future scientists in fields such as molecular microbiology, genetics, clinical immunology, and bioinformatics.

Her unwavering passion for science, coupled with her commitment to humanitarian work—evident in her volunteerism with Together for Human and Environment Association and Community Anti-Drug Collision of Ankawa—reflects her dedication to both scientific and social progress.

Through her relentless pursuit of knowledge and research excellence, Raya continues to pioneer advancements in molecular diagnostics and biomedical research, shaping the future of science and healthcare in Iraq and beyond. 🌟

Publication Top Notes : Molecular biology, Genetics, Neuroscience, Cancer Research

  1. “The miR-146a-5p and miR-125b-5p levels as biomarkers for early prediction of Alzheimer’s disease.”
    • Year: 2022
    • Journal: Human Gene
    • DOI: 10.1016/j.humgen.2022.201129
    • Citations: This study has been referenced in subsequent research exploring microRNA biomarkers in neurodegenerative diseases.
  2. “Telomerase Reverse Transcriptase and Telomerase RNA Component Gene Expression as Novel Biomarkers for Alzheimer’s Disease.”
    • Year: 2022
    • Journal: Cellular and Molecular Biology
    • DOI: 10.14715/cmb/2022.68.9.2
    • Citations: Cited in research focusing on telomerase activity in neurodegenerative conditions.
  3. “Incidence of Candida Species Biofilms in Pediatric Cancer Patients Undergoing Chemotherapy Treatment.”
    • Year: 2022
    • Journal: BioMed Target Journal
    • DOI: 10.59786/bmtj.114
    • Citations: Referenced in studies examining fungal infections in immunocompromised patients.
  4. “Epidemiological Study and Clinical Presentation of Urinary Tract Infection.”
    • Year: 2022
    • Journal: BioMed Target Journal
    • DOI: 10.59786/bmtj.115
    • Citations: Cited in epidemiological research on urinary tract infections.
  5. “MicroRNAs and Telomerase Gene Expression in Alzheimer’s Disease.”
    • Year: 2022
    • Publication Type: Book
    • Link: 978-620-7-47351-9
    • Citations: Serves as a reference in academic discussions on genetic markers in Alzheimer’s disease.
  6. “The Outbreak of SARS-CoV-2 Variants in Iraqi Kurdistan Region.”
    • Year: 2022
    • Journal: The Journal of Infection in Developing Countries
    • DOI: 10.3855/jidc.19351
    • Citations: Included in studies analyzing COVID-19 variant outbreaks.
  7. “Fungal Disease Incidence and Prevalence in Iraq – Preliminary Estimates.”
    • Year: 2024
    • Journal: Journal de Mycologie Médicale
    • DOI: 10.1016/j.mycmed.2024.101516
    • Citations: Referenced in research on fungal disease epidemiology in the Middle East.
  8. “Revolutionizing Medicine: Recent Developments and Future Prospects in Stem Cell Therapy.”
    • Year: 2024
    • Journal: Journal of Stem Cells
    • DOI: 10.1097/JS9.0000000000002109
    • Citations: Cited in discussions on advancements in stem cell research.
  9. “Human ACE and ACE2 Genes Variants and COVID-19 Disease in Iraqi Kurdistan Region.”
    • Year: 2024
    • Journal: Journal of Medical Virology
    • Status: Accepted for publication
    • Citations: Anticipated to contribute to genetic studies related to COVID-19 susceptibility.

 

 

 

 

 

Ms Himani Shah | Cancer cell biology | Best Researcher Award | 1255

Ms Himani Shah | Cancer cell biology | Best Researcher Award

PhD student at Institute for Molecular Bioscience,Australia

Himani Shah is a doctoral candidate in the Institute for Molecular Bioscience (IMB) at The University of Queensland (UQ), Australia, with expertise in cancer research, molecular biology, and biotechnology. She is investigating the cellular mechanisms of G protein-coupled receptors (GPCRs) and their role in cancer progression. Her academic journey has been marked by outstanding performance, earning top grades and recognition. Her research has significant clinical implications for cancer therapy, especially women’s cancers.

Publication Profile

Google Scholar 

Education 🎓

  • Doctor of Philosophy (2021-Present), IMB, UQ, Australia (Supervisors: Prof. David Fairlie & Dr. Junxian Lim). Thesis submission by November 2024.
  • Master of Biotechnology Research Extensive (2019-2020), SCMB, UQ, Australia, GPA 6.56/7.0 (Supervisors: Dr. Roberta Mazzieri, Prof. David Fairlie, Dr. Junxian Lim).
  • Bachelor of Science in Biotechnology (2015-2018), Mithibai College, University of Mumbai, India, GPA 7.0/7.0.

Professional Experience 💼

Himani has gained extensive experience in both research and teaching roles. She is currently a casual academic staff member at SCMB, UQ, tutoring in molecular biology, microbiology, genetics, and biochemistry. Additionally, she has worked as a research tutor at TRI, mentoring high school students in molecular biology techniques. Her practical experience includes extensive laboratory management, training, and mentoring junior researchers.

Research Interests 🔬

Himani’s primary research interests focus on the role of GPCRs in cancer biology. She is investigating how protease-activated receptors, particularly PAR2, influence cancer cell apoptosis and could be leveraged as therapeutic targets, especially in women’s cancers. Her past research projects have also included the role of C3aR in kidney cancer and the characterization of a preclinical metastatic breast cancer model.

Awards and Honors 🏆

  • 2024: HDR IMB Completion Award, Best Poster Presentation at CCDD Symposium.
  • 2023: 3MT IMB Heats – People’s Choice Winner.
  • 2021: SPARQ-ed Research Immersion Scholarship, TRI; Research Training Program UQ Graduate School Scholarship.
  • 2020: Dean’s Commendation for Academic Excellence, UQ.

Achievements 🌟

Himani has achieved success in both research and community engagement. She was awarded People’s Choice at the Three Minute Thesis (3MT) competition at UQ in 2023. Additionally, her participation in various conferences and symposia, both as an oral and poster presenter, highlights her commitment to advancing scientific knowledge.

Upcoming Projects 🚀

Himani’s upcoming work focuses on investigating new therapeutic avenues for women’s cancers, particularly through the modulation of protease-activated receptors. She will also be presenting her research findings at various conferences in 2024, including the European Association for Cancer Research Congress in Rotterdam.

Publication📚

  • Shah, H., Hill, T. A., Lim, J., & Fairlie, D. P. (2023). Protease-activated receptor 2 attenuates doxorubicin-induced apoptosis in colon cancer cells. Journal of Cell Communication and Signaling, 17, 1293-1307.
  • Shah, H., Fairlie, D. P., & Lim, J. (2024). Protease-activated receptor 2: A promising therapeutic target for women’s cancers. Journal of Pharmacology and Experimental Therapeutics. DOI: 10.1124/jpet.124.002176. Special edition: Breaking barriers in Women’s Cancer Treatment: Innovative Approaches and Experimental Therapeutics.